CareDx, Inc. - Common Stock (NQ:CDNA)

88.21 +16.69 (+23.34%)

Delayed Quote Updated: 11:41 AM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CareDx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plans ↗

June 08, 2026

CareDx (NASDAQ:CDNA) executives outlined the company’s strategy to focus on precision diagnostics, expand into minimal residual disease testing and improve profitability during a Goldman Sachs-hosted...

Via MarketBeat

Topics Intellectual Property

CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies ↗

June 07, 2026

CareDx (NASDAQ:CDNA) executives outlined the company’s growth strategy, first-quarter performance and pipeline priorities during a presentation at the Jefferies Healthcare Conference, emphasizing...

Via MarketBeat

CAREDX INC (NASDAQ:CDNA) Shows Perfect Minervini Trend Template and High Growth Momentum Setup ↗

May 30, 2026

Via Chartmill

CareDx to Participate in Upcoming Investor Conferences

May 20, 2026

From CareDx, Inc.

Via Business Wire

CareDx Announces Dismissal of 2021 Qui Tam Suit

May 11, 2026

From CareDx, Inc.

Via Business Wire

CareDx (NASDAQ:CDNA) Beats Q1 Estimates and Raises Full-Year Guidance, But Stock Slips ↗

April 28, 2026

Via Chartmill

CareDx Inc (NASDAQ:CDNA) Reports Strong Revenue Beat but Profitability Concerns Weigh on Shares ↗

February 24, 2026

Via Chartmill

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 01, 2026

From CareDx, Inc.

Via Business Wire

CareDx (CDNA) Q1 2026 Earnings Call Transcript ↗

April 28, 2026

CareDx (CDNA) Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Get insights into the top gainers and losers of Tuesday's after-hours session. ↗

April 28, 2026

Via Chartmill

CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing

April 28, 2026

From CareDx, Inc.

Via Business Wire

CareDx Announces First Quarter 2026 Financial Results

April 28, 2026

From CareDx, Inc.

Via Business Wire

CareDx (CDNA) Q2 2025 Earnings Transcript ↗

April 28, 2026

CareDx (CDNA) Q2 2025 Earnings Transcript

Via The Motley Fool

CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation’s 46th Annual Meeting

April 21, 2026

From CareDx, Inc.

Via Business Wire

CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing

April 20, 2026

From CareDx, Inc.

Via Business Wire

Thursday's session: gap up and gap down stocks ↗

April 16, 2026

Via Chartmill

CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results

April 15, 2026

From CareDx, Inc.

Via Business Wire

CareDx to Report First Quarter 2026 Financial Results on April 28, 2026

April 14, 2026

From CareDx, Inc.

Via Business Wire

CareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets

March 05, 2026

From CareDx, Inc.

Via Business Wire

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 27, 2026

From CareDx, Inc.

Via Business Wire

CareDx (CDNA) Q4 2025 Earnings Call Transcript ↗

February 24, 2026

CareDx (CDNA) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer

February 24, 2026

From CareDx, Inc.

Via Business Wire

CareDx Announces Fourth Quarter and Full Year 2025 Financial Results

February 24, 2026

From CareDx, Inc.

Via Business Wire

CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference

February 18, 2026

From CareDx, Inc.

Via Business Wire

Power Solutions Stock Up 140% as $6.36 Million Exit Follows 62% Sales Surge ↗

February 16, 2026

Power Solutions International designs and manufactures advanced engines and power systems for industrial and transportation markets.

Via The Motley Fool

Topics Energy Regulatory Compliance

Freshworks Falls 60% in a Year as $7.5 Million Sale Shrinks Stake to 3.1% of This Portfolio's Assets ↗

February 16, 2026

This SaaS firm delivers cloud-based business software worldwide, focusing on subscription-driven customer and IT service solutions.

Via The Motley Fool

Topics Regulatory Compliance

Air Lease Stock Up 43% as Investor Trims $6.9 Million Stake Despite $1 Billion Profit Year ↗

February 16, 2026

Air Lease Corporation provides global airlines with commercial jet leasing, sales, and fleet management services across a diverse portfolio.

Via The Motley Fool

Topics Regulatory Compliance

Five9 Stock Down 60% This Past Year, but One Investor Just Lifted Stake With $3.5 Million Buy ↗

February 16, 2026

Five9 delivers cloud-based contact center software for enterprises, serving clients across finance, healthcare, and technology sectors.

Via The Motley Fool

Freshworks Stock Down 60% in One Year as Revenue Jumps 16% and One Investor Sells $7 Million in Shares ↗

February 16, 2026

Freshworks delivers cloud-based SaaS solutions for customer engagement, IT service management, and business process automation.

Via The Motley Fool

Topics Regulatory Compliance

CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy

February 12, 2026

From CareDx, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.